Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition184
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence82
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review63
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis60
Genetic heterogeneity of group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination59
Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis58
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future57
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits56
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation49
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials46
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review40
The antifungal pipeline for invasive fungal diseases: what does the future hold?39
Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)39
Is the world crippled by antimicrobial resistance, or simply lacking information?38
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status38
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice36
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?36
Computational analysis of target genes in monkeypox virus infection and potential therapeutic precursors35
Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs34
The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-1932
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae31
Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience31
How can we tackle the overuse of antibiotics in low- and middle-income countries?31
Neonatal ocular prophylaxis in the United States: is it still necessary?28
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects28
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections27
Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals- a threshold logistic modelling approach27
Health literacy, knowledge, household disposal, and misuse practices of antibiotics among UAE residents: a nationwide cross-sectional study27
0.081283092498779